Hemochromatosis Market, By Type, By Diagnosis Method (Blood Tests, Imaging Techniques, By Treatment Type, By Age Group, By End User, By Geography

PUBLISHED: November 28, 2024

PAGES: 140 Pages

DELIVERY TIME: 2-3 business days

ADD TO COMPARE

SELECT AN OPTION

Description

The global hemochromatosis market is estimated to be valued at USD 1.60 Bn in 2024 and is expected to reach USD 2.41 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 6% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	US$ 1.60 Bn
Historical Data for:	2019 To 2023	Forecast Period:	2024 To 2031
Forecast Period 2024 to 2031 CAGR:	6.00%	2031 Value Projection:	US$ 2.41 Bn

Figure. Hemochromatosis Market Share (%), By Region 2024

Several factors such as increasing prevalence of hereditary hemochromatosis and rising awareness regarding iron overload disorders are driving the demand for hemochromatosis treatment and management.

Market Dynamics:

The global hemochromatosis market growth is primarily driven by the rising prevalence of hereditary hemochromatosis across the globe. As per estimates from Medscape, in June 2023, around 1 million Americans suffer from hereditary hemochromatosis which remains undiagnosed. Increasing awareness about the early diagnosis and treatment of iron overload disorders is positively impacting the market growth. Moreover, increasing adoption of screening programs for the early detection of hemochromatosis is further fueling the market growth. However, high costs associated with genetic testing and liver biopsy procedures may hinder the market growth to some extent. Nevertheless, ongoing research for the development of advanced diagnostics and introduction of genetic testing are expected to create lucrative opportunities for market players over the forecast period.

Key Features of the Study:

This report provides in-depth analysis of the global hemochromatosis market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global hemochromatosis market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study Novartis AG, Sanofi S.A., Amgen Inc., Takeda Pharmaceutical Company Limited, Pfizer Inc., Ironwood Pharmaceuticals, Inc., Celgene Corporation, Genentech, Inc., Daiichi Sankyo Company, Limited, Teva Pharmaceutical Industries Ltd., HemoShear Therapeutics, LLC, Erytech Pharma S.A., Alnylam Pharmaceuticals, Inc., HemaCare Corporation, and Invitae Corp.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global hemochromatosis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global hemochromatosis market.

Market Segmentation

By Type Insights (Revenue, USD Bn, 2019 - 2031)
- Primary Hemochromatosis (Hereditary)
- Secondary Hemochromatosis (Acquired)
By Diagnosis Method Insights (Revenue, USD Bn, 2019 - 2031)
- Blood Tests
- Serum Ferritin
- Transferrin Saturation
- Imaging Techniques
- Magnetic Resonance Imaging (MRI)
- Computed Tomography (CT) scans
- Liver Biopsy
- Genetic Testing
By Treatment Type Insights (Revenue, USD Bn, 2019 - 2031)
- Phlebotomy
- Chelation Therapy
- Dietary Management
- Others
By Age Group Insights (Revenue, USD Bn, 2019 - 2031)
- Pediatric
- Adult
- Geriatric
By End User Insights (Revenue, USD Bn, 2019 - 2031)
- Hospitals
- Diagnostic Laboratories
- Surgical Centers
- Home Care Settings
Regional Insights (Revenue, USD Bn, 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Novartis AG
- Sanofi S.A.
- Amgen Inc.
- Takeda Pharmaceutical Company Limited
- Pfizer Inc.
- Ironwood Pharmaceuticals, Inc.
- Celgene Corporation
- Genentech, Inc.
- Daiichi Sankyo Company, Limited
- Teva Pharmaceutical Industries Ltd.
- HemoShear Therapeutics, LLC
- Erytech Pharma S.A.
- Alnylam Pharmaceuticals, Inc.
- HemaCare Corporation
- Invitae Corp.

Product Code: CMI7544

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Hemochromatosis Market, By Type
- Global Hemochromatosis Market, By Diagnosis Method
- Global Hemochromatosis Market, By Treatment Type
- Global Hemochromatosis Market, By Age Group
- Global Hemochromatosis Market, By End User
- Global Hemochromatosis Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Driver
- Restraint
- Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Hemochromatosis Market, By Type, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Primary Hemochromatosis (Hereditary)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Secondary Hemochromatosis (Acquired)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

5. Global Hemochromatosis Market, By Diagnosis Method, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Blood Tests
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Serum Ferritin
Transferrin Saturation
Imaging Techniques
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Magnetic Resonance Imaging (MRI)
Computed Tomography (CT) scans
Liver Biopsy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Genetic Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Hemochromatosis Market, By Treatment Type, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Phlebotomy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Chelation Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Dietary Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Hemochromatosis Market, By Age Group, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Geriatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Hemochromatosis Market, By End User, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Home Care Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

9. Global Hemochromatosis Market, By Region, 2019 - 2031, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2020 - 2031, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Diagnosis Method, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Treatment Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Diagnosis Method, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Treatment Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Diagnosis Method, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Treatment Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Diagnosis Method, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Treatment Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Diagnosis Method, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Treatment Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Diagnosis Method, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Treatment Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2019 - 2031, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

10. Competitive Landscape

Novartis AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sanofi S.A.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Amgen Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Takeda Pharmaceutical Company Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Pfizer Inc.
Ironwood Pharmaceuticals, Inc.
Celgene Corporation
Genentech, Inc.
Daiichi Sankyo Company, Limited
Teva Pharmaceutical Industries Ltd.
HemoShear Therapeutics, LLC
Erytech Pharma S.A.
Alnylam Pharmaceuticals, Inc.
HemaCare Corporation
Invitae Corp.